Author Index: H
Author Index: H
A Health System with a Memory for Adverse Events, but at what Cost? An Economic Analysis of the UK's National Reporting and Learning System (NRLS),
SOCIAL DETERMINANTS OF HEALTH: DO THE DATA SUPPORT THE RHETORIC?,
Estimating the health burden and costs of patient safety events using English hospital data
Cost effectiveness of adding bevacizumab to first line therapy of patients with advanced ovarian cancer,
Pregabalin (Lyrica®) is cost-effective over Gabapentin (Neurontin®) as a First-Line Treatment for Neuropathic Pain (NeP) Management after Spinal Cord Injury (SCI),
Cost-effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis,
Cost-effectiveness comparison of Denosumab and Zoledronic Acid in the treatment of Postmenopausal Osteoporosis,
Evaluating the Impact of Marijuana Use on Metabolic Syndrome Using Data from the Continuous National Health and Nutrition Examination Survey,
Provider Preferences for Interventions for Reducing Inappropriate Antibiotic Prescribing,
A Behavioral Economics Multi-site Randomized Trial to Reduce Provider Antibiotic Overprescribing,
Cost-effectiveness analysis of abiraterone and sipuleucel-T in metastatic castration-resistant prostate cancer,
The Cost-Effectiveness of Screening and Management Strategies for Familial Hypercholesterolemia in the United States: A Markov Model Analysis,
A COST-EFFECTIVENESS ANALYSIS OF PRE-EXPOSURE PROPHYLAXIS (PrEP) FOR THE PREVENTION OF HIV IN THE LOS ANGELES COUNTY MSM POPULATION,
Cost-Effectiveness Analysis of Diagnostic Methods for Clostridium difficile Infection,
Medical Cost Offsets from Prescription Drug Utilization among Medicare Beneficiaries
Determinants and Technical Efficiency of Turkish Hospitals: An Application of Stochastic Frontier Analysis,
Behavioral and Social Determinants of Smoking and Support for Tobacco-Free Campus Policies among Students, Faculty and Staff: Evidence from South Carolina,
Health Information, Taxes and Life-Course Smoking: Evidence from Turkey
The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics,
THE IMPACT OF FINANCIAL INCENTIVES AND INFORMATION ON REFERRALS FOR SPECIALTY CARE: EVIDENCE FROM A PATIENT-CENTERED MEDICAL HOME PROGRAM,
Automated Disease Detection and the Demand for Human Experts: The Case of Diabetic Retinopathy
How Do Health Insurer Market Concentration and Bargaining Power with Hospitals Affect Health Insurance Premiums?,
How Does Regulation of the Small Group Market Affect Firm Self-Insurance and Implications for the Affordable Care Act,
The Costs of Clinical Trials,
Transplant Market Concentration and the Underutilization of Viable Donors: Theory and Evidence from Liver Transplants
Out-of-Pocket Spending in the Marketplaces for Adults in States Not Expanding Medicaid,
Health Insurance and the Supply of Entrepreneurs: New Evidence from the Affordable Care Act's Dependent Coverage Mandate,
Do Insurers Risk-Select Against Each Other? Evidence from Medicaid and Implications for Health Reform
Quality Reporting and Private Prices: Evidence from the Nursing Home Industry,
Malpractice Laws and Incentives to Shield Assets: Evidence from Nursing Homes,
Market Competition and the Quality of Nursing Home Care,
New Evidence on the Persistence of High Health Spending,
Does Home Equity Substitute Long-term Care Purchases?,
The Effects of Quality Standards on Healthcare Provider Behavior: Evidence from Organ Transplantation
A COMPARISON OF AMBULATORY SURGERY CENTER PRODUCTION COSTS AND MEDICARE PAYMENTS,
Are Higher-Volume Hospitals Really Better?,
How do State Revenue Swings Influence the Provision of Health, Education, and Welfare Services?,
The effect of the diffusion of the Surgical Robot on the hospital-level utilization of partial nephrectomy
Moral Hazard and Less Invasive Medical Treatment for Coronary Artery Disease: An Analysis of Smoking in the National Health Interview Survey,
Moral Hazard and Less Invasive Medical Treatment for Coronary Artery Disease,
Measuring the Hospital Length of Stay/Readmission Cost Trade-off under a Bundled Payment Mechanism,
Do Patient‐Centered Medical Homes Reduce Emergency Department Visits?,
Fighting Crime through Treatment: The Effect of Treatment for Substance Use Disorder on Crime,
Hospital responses to price changes: Evidence from the 2007 switch to MS-DRGs,
Specification in difference-in-differences models,
The Impact of Electronic Health Record Adoption and Integration on Physician Productivity and Health Outcomes,
Hospital and physician prices and treatment choice in labor and delivery,
Inertia in physicians practice patterns
Heterogeneity, Censoring and Endogeneity in Estimates of Response to Soft Drink Tax: Finite Mixture Tobit and Censored Quantile Regression Approaches,
Mis-Reporting and heterogeneous reporting behaviours in models of self reported health,
Anchoring vignettes and measures of health: adjusting for systematic differences in reporting behaviour,
Heavy Drinking, Health and Mental Wellbeing
Billing and Reimbursement Outcomes for School-Located Vaccination for Influenza in Two U.S. Areas,
School-Located Vaccination for Influenza: A Comprehensive Estimate of Program Costs,
The Impact of Obesity Duration on Healthcare Use,
Health Services Use and Health Status Among People with Diabetes Mellitus and Cardiovascular Diseases
Impact of the 2009 United States Preventive Services Task Force Recommendations for Breast Cancer Screening on Utilization of Mammography: A Longitudinal Data Analysis,
A News Media Analysis of the Economic and Reputational Penalties of the Hospital Readmissions Reduction Program,
Inertia in physicians practice patterns,
Pricing trends in the market for anticancer drugs
Patient Responses to Incentives in Consumer-Directed Health Plans: Evidence from Pharmaceuticals,
Price Shopping in Consumer Directed Health Plans,
Shopping for a Physician: Is Per Visit Costs Useful Information?,
The Effects of Vertical Integration on Health Care Costs and Patient Outcomes,
The Long Term Effects of Consumer-Directed Health Plans on Health Care Costs